UOG Journal Club: July 2018
Fetal Medicine Foundation fetal and neonatal population weight charts
Expanding analysis of cell-free DNA to deliver safe, accurate, speedy diagnosis of skeletal dysplasias and other monogenic disorders
This lecture was delivered at ISUOG's World Congress in Rome, in 2016.
Beyond NIPT for the common trisomies: zooming in and out on the fetal genome
This lecture was delivered at ISUOG's World Congress in Montreal, in 2015.
NIPT based on cfDNA: the basics
This lecture was delivered at ISUOG's World Congress in Montreal, in 2015.
UOG Journal Club: June 2018
ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm
UOG Journal Club: May 2018
Prevention of preterm birth with pessary in singletons (PoPPs): randomized controlled trial
UOG Journal Club: April 2018
Effectiveness of 12–13-week scan for early diagnosis of fetal congenital anomalies in the cell-free DNA era
UOG Journal Club: March 2018
Prognostic accuracy of cerebroplacental ratio and middle cerebral artery Doppler for adverse perinatal outcome: systematic review and meta-analysis
UOG Journal Club: February 2018
First-trimester prediction of surgical outcome in abnormally invasive placenta using the cross-over sign
UOG Journal Club: Noviembre 2017
Resultado de embarazo gemelar monocorial con restricción en crecimiento intrauterino selectivo de acuerdo al patrón de flujometria Doppler de arteria umbilical del gemelo pequeño: revisión sistemática y meta- análisis
The scope of sonographic screening and of a detailed anatomical survey at 12 weeks
This lecture was delivered as part of the workshop " Ultrasound and genetic diagnostics at 12 weeks" at ISUOG's World Congress in Vienna, in 2017.
LIVE SCAN: How I optimise detection of anomalies at 12 weeks [Supported by Toshiba]
This lecture was delivered as part of the workshop "Ultrasound and genetic diagnostics at 12 weeks" at ISUOG's World Congress in Vienna, in 2017.
The potential of the biochemical component of combined screening in the era of NIPT: beyond T21/18/13
This lecture was delivered as part of the workshop "Ultrasound and genetic diagnostics at 12 weeks" at ISUOG's World Congress in Vienna, in 2017.
DEBATE: It is still worth measuring nuchal translucency in 2017? (D. Bettelheim, Austria; J. Hyett, Australia)
This lecture was delivered at ISUOG's World Congress in Vienna, in 2017.
Non-invasive screening for genetic conditions: where will we be by Berlin 2019?
This lecture was delivered as part of the workshop "Ultrasound and genetic diagnostics at 12 weeks" at ISUOG's World Congress in Vienna, in 2017.
Chromosomal microarray as a primary diagnostic genomic tool for pregnancies defined as being at increased risk within a population-based combined first trimester screening program (I. Vogel, DK)
This lecture was delivered at ISUOG's World Congress in Vienna, in 2017.
Chromosomal abnormalities detected by cell-free DNA testing as a contingent approach versus direct invasive prenatal diagnosis
This lecture was delivered at ISUOG's World Congress in Vienna, in 2017.
Comparison between first trimester combined screening and a combination between ultrasound and cell-free DNA
This lecture was delivered at ISUOG's World Congress in Vienna, in 2017.
Whole-genome array as a first-tier cytogenetic test in routine prenatal diagnosis (M. Hynek, Czechia)
This lecture was delivered at ISUOG's World Congress in Vienna, in 2017.
Fetal abnormalities associated with increased nuchal translucency versus cell-free fetal DNA (F. Bardi, Netherlands)
This lecture was delivered at ISUOG's World Congress in Vienna, in 2017.